IART vs IRMD: stock comparison and AI forecast
Integra Lifesciences Holdings Corp (IART) and Iradimed Corp (IRMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
IART Integra Lifesciences Holdings Corp
- Market Cap
- $1.06B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
IRMD Iradimed Corp
- Market Cap
- $981M
- P/E Ratio
- 41.9x
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- IART and IRMD have similar market capitalizations ($1.06B and $981M).
- IART carries 2.29 times debt per unit of equity, against 0.14 times for IRMD.
- IRMD yields 1.65% in dividends; IART pays none.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | IART | IRMD |
|---|---|---|
| Market Cap | $1.06B | $981M |
| P/E Ratio | – | 41.89x |
| P/B Ratio | 0.99x | 9.21x |
| Dividend Yield | – | 1.65% |
| EPS | $-0.17 | $1.83 |
| Book Value/Share | $13.71 | $8.33 |
| Revenue/Share | $21.30 | $6.99 |
| FCF/Share | $1.10 | $2.04 |
Profitability & Margins
| Metric | IART | IRMD |
|---|---|---|
| ROE | – | 22.5% |
| ROA | – | 19.8% |
| ROIC | 2.3% | 26.1% |
| Gross Margin | 52.4% | 75.5% |
| Operating Margin | 4.4% | 32.3% |
| Net Margin | – | 26.9% |
| EBT Margin | 1.4% | 34.8% |
| Tax Rate | 41.7% | 22.9% |
Financial Health
| Metric | IART | IRMD |
|---|---|---|
| Current Ratio | 3.62x | 8.99x |
| Quick Ratio | 2.21x | 7.68x |
| D/E Ratio | 2.29x | 0.14x |
| Financial Leverage | 3.29x | 1.14x |
| Interest Coverage | 0.3x | – |
| Working Capital | $861M | $82M |
Cash Flow
| Metric | IART | IRMD |
|---|---|---|
| Operating Cash Flow | $140M | $27M |
| Free Cash Flow | $86M | $26M |
| Capital Spending | -$55M | -$1M |
| OCF Growth YoY | 57.2% | 8.6% |
| FCF Growth YoY | – | 77.2% |
| FCF/Sales | 5.2% | 29.3% |
| CapEx/Sales | 3.3% | 1.1% |
Operational Efficiency
| Metric | IART | IRMD |
|---|---|---|
| Asset Turnover | 0.47x | 0.74x |
| Receivables Turnover | 6.7x | 6.5x |
| Inventory Turnover | 1.7x | 1.6x |
| Fixed Assets Turnover | 3.8x | 3.7x |
| Days Sales Outstanding | 55 days | 56 days |
| Days Inventory | 215 days | 225 days |
| Payables Period | – | 40 days |
| Cash Conversion Cycle | – | 241 days |
Income Statement
| Metric | IART | IRMD |
|---|---|---|
| Total Revenue | $1.66B | $89M |
| Operating Income | $73M | $29M |
| Net Income | – | $24M |
| R&D Expense | $94M | $3M |
| SG&A Expense | $685M | $41M |
| Cost of Goods Sold | $789M | $22M |
Dividend & Shareholder Information
| Metric | IART | IRMD |
|---|---|---|
| Dividends Per Share | – | $1.27 |
| Payout Ratio | – | 69.4% |
| Shares Outstanding | 78M | 13M |
| Net Income Growth | – | 10.0% |
| EPS Growth | – | 19.6% |
IART vs IRMD: stock comparison and AI forecast
Which is bigger, IART or IRMD?
IART and IRMD have similar market capitalizations ($1.06B and $981M).
Which one does Intratio's AI model rank higher, IART or IRMD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.